Bioarticure Medical Technology (Shanghai) Co., Ltd. announced that it has signed an agreement to raise CNY 20,000,006.4064 in an equity funding on November 13, 2023. The transaction will include participation from returning investor, Shanghai Kinetic Medical Co., Ltd out of which CNY 172,336 will go to registered capital and its stake will increase from 24.1332% to 32.9293% in the company. The transaction has been approved at the eleventh meeting of the fifth board of directors and eleventh meeting of the fifth supervisory board.
Shanghai Kinetic Medical Co., Ltd
Equities
300326
CNE100001FG9
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.98 CNY | +1.43% | +4.62% | -21.33% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.33% | 493M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- 300326 Stock
- News Shanghai Kinetic Medical Co., Ltd
- Bioarticure Medical Technology Co., Ltd. announced that it expects to receive CNY 20.000006 million in funding from Shanghai Kinetic Medical Co., Ltd